Name
GS5-02 GeparOLA - GBG 90 Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative early breast cancer and homologous recombination deficiency - long-term survival of the GeparOLA study
Date & Time
Tuesday, December 6, 2022
Speakers
Virtual Session Link